CINECA IRIS Institutional Research Information System

FALLAHI, POUPAK
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.228
EU - Europa 5.933
AS - Asia 2.298
AF - Africa 151
SA - Sud America 29
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.897
IT - Italia 2.765
SE - Svezia 1.187
CN - Cina 1.087
BG - Bulgaria 707
VN - Vietnam 404
SG - Singapore 383
CA - Canada 327
DE - Germania 326
GB - Regno Unito 203
FI - Finlandia 198
TR - Turchia 196
UA - Ucraina 153
RU - Federazione Russa 145
CI - Costa d'Avorio 81
IN - India 79
HK - Hong Kong 78
CH - Svizzera 44
FR - Francia 40
BE - Belgio 37
SN - Senegal 34
IQ - Iraq 29
NG - Nigeria 26
NL - Olanda 25
PL - Polonia 23
BR - Brasile 14
CZ - Repubblica Ceca 13
AT - Austria 12
ES - Italia 12
RO - Romania 11
IR - Iran 10
IE - Irlanda 8
EU - Europa 6
GR - Grecia 6
JP - Giappone 6
PT - Portogallo 6
AU - Australia 5
EG - Egitto 5
CO - Colombia 4
HU - Ungheria 4
IL - Israele 4
KR - Corea 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CL - Cile 3
RS - Serbia 3
TW - Taiwan 3
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 24.652
Salva come PNG Salva come JPEG
Città #
Fairfield 2.488
Woodbridge 2.049
Houston 1.379
Chandler 1.180
Ann Arbor 1.165
Ashburn 1.116
Seattle 1.067
Serra 985
Wilmington 863
Cambridge 861
Sofia 707
Milan 594
Beijing 440
New York 431
Princeton 343
Ottawa 307
Lawrence 286
Medford 264
Pisa 234
Nanjing 193
Jacksonville 184
Izmir 180
Des Moines 179
Dong Ket 174
Singapore 147
San Diego 124
Florence 106
Dearborn 87
Abidjan 81
Hong Kong 73
Rome 71
Boulder 65
Nanchang 62
Ogden 55
Frankfurt am Main 52
Kunming 50
London 49
Redwood City 47
Bremen 45
Falls Church 42
Hebei 41
Norwalk 40
Changsha 39
Shenyang 39
Brussels 36
Bern 34
Dakar 34
Jüchen 31
Los Angeles 31
Boardman 27
Washington 27
Jiaxing 25
Lagos 25
Rho 25
Hefei 24
Pune 24
Tianjin 23
Chicago 22
Phoenix 21
Hyderabad 20
Sulaymaniyah 20
Indiana 19
Livorno 17
Warsaw 17
Zhengzhou 17
Guangzhou 16
Massa 16
San Francisco 16
Carrara 14
Lancaster 13
Parma 13
Detroit 12
Amsterdam 11
Kent 11
Vienna 11
Chengdu 10
Jinan 10
Auburn Hills 9
Changchun 9
Lanzhou 9
Shanghai 9
Sundbyberg 9
Dublin 8
Kilburn 8
Edinburgh 7
Hangzhou 7
Ningbo 7
Renton 7
São Paulo 7
Bergamo 6
Fremont 6
Grafing 6
Nürnberg 6
Toronto 6
Wuhan 6
Camaiore 5
Cascina 5
Grosseto 5
Lappeenranta 5
Lucca 5
Totale 19.813
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 186
A new class of tyrosine kinase inhibitors, “pyrazolo[3,4-d]pyrimidinic”compounds, has antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 184
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 160
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 157
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 155
B-cells and mixed cryoglobulinemia. 154
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 153
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 148
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 147
HCV-related autoimmune and neoplastic disorders: the HCV syndrome 141
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats 140
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 140
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 140
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 139
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts. 136
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 136
Sorafenib and Thyroid Cancer 130
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 130
Cytokines and HCV-Related Disorders. 128
Sunitinib in the treatment of thyroid cancer 128
Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. 124
Cytokines and HCV-related autoimmune disorders 123
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 123
Cabozantinib in Thyroid Cancer 122
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. 121
The Endocrinology of Liver Disease. 121
RET TKI: Potential Role in Thyroid Cancers 121
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 121
Aggressive thyroid cancer: targeted therapy with sorafenib 120
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 120
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 120
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 119
An iron regulatory gene signature in breast cancer: More than a prognostic genetic profile? 118
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 118
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 118
Sorafenib in the treatment of thyroid cancer 118
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 117
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 117
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 117
New targeted molecular therapies for dedifferentiated thyroid cancer. 115
Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules 115
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 113
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 113
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 113
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 112
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 111
New targeted therapies for anaplastic thyroid cancer. 111
Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident 111
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine. 110
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 110
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 110
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 109
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 109
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 108
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas 108
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 107
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer 106
Thyroid cancer in HCV-related mixed cryoglobulinemia patients. 105
Hepatitis C virus infection - Evidence for an association with type 2 diabetes 105
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 105
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 105
The emerging extrahepatic manifestations oh hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia. 104
null 104
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation 104
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer 104
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 104
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis 103
null 103
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 103
null 103
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study 102
Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. 101
Novel treatment options for anaplastic thyroid cancer 101
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 101
Dedifferentiated thyroid cancer: a therapeutic challenge 100
null 100
Autoimmune thyroid disorders 100
Body composition and cardiac dimensions in elite rhythmic gymnasts 100
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 100
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 100
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 99
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism 99
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. 99
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 99
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 99
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes 98
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. 98
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. 98
Selective use of vandetanib in the treatment of thyroid cancer 98
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 98
L’esperienza della Medicina del Lavoro della Azienda Ospedaliero-Universitaria Pisana nella sorveglianza sanitaria degli ex-esposti ad amianto, alla luce delle linee di indirizzo della regione Toscana 98
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 97
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease 97
null 97
Prevalence of hypothyroidism and Graves disease in sarcoidosis 96
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 96
Current and future immunotherapies for thyroid cancer 96
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 96
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 95
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer 95
Totale 11.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.662 639 337 935 355 520 548 699 620 1.021 430 405 153
2020/20212.728 267 224 298 98 182 98 83 361 172 322 143 480
2021/20223.378 70 154 119 214 554 460 97 223 171 145 228 943
2022/20233.428 502 409 225 306 373 504 58 249 498 15 242 47
2023/20242.911 290 325 360 230 429 521 144 108 47 54 101 302
2024/2025197 197 0 0 0 0 0 0 0 0 0 0 0
Totale 25.724